PillRx only · Tablet, Film Coated · Oral
Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide
Amlodipine Besylate + Hydrochlorothiazide + Olmesartan Medoxomil
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 15 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.031
Latest avg · Jul 22, 2026
-21%
Since Dec 17, 2025
3
Active US suppliers
83%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
4.5K
Rx · 2026 Q1
205K
Units dispensed
+45%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Camber Pharmaceuticals, Inc. | unknown | 15 | SUPPLYING |
| Macleods Pharmaceuticals Limited | unknown | 10 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 5 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.